EUVIMEDEUVIMED entdecken
Crossref

Removing the signal is not correcting the imbalance: sFlt-1–depletion trials in preeclampsia need fetal as well as maternal endpoints

Maria Cezara Mureșan, Marius Bogdan Mureșan

Pregnancy Hypertension · 2026-12 · 46 · 101545

DOI: 10.1016/j.preghy.2026.101545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pregnancy Hypertension, 2026-12. Verfasst von Maria Cezara Mureșan und 1 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mureșan, M. C., & Mureșan, M. B. (2026). Removing the signal is not correcting the imbalance: sFlt-1–depletion trials in preeclampsia need fetal as well as maternal endpoints. Pregnancy Hypertension, 46, 101545. https://doi.org/10.1016/j.preghy.2026.101545

Vancouver

Mureșan MC, Mureșan MB. Removing the signal is not correcting the imbalance: sFlt-1–depletion trials in preeclampsia need fetal as well as maternal endpoints. Pregnancy Hypertension. 2026;46:101545. doi:10.1016/j.preghy.2026.101545

BibTeX
@article{Murean2026,
  author = {Mureșan, Maria Cezara and Mureșan, Marius Bogdan},
  title = {Removing the signal is not correcting the imbalance: sFlt-1–depletion trials in preeclampsia need fetal as well as maternal endpoints},
  journal = {Pregnancy Hypertension},
  year = {2026},
  volume = {46},
  pages = {101545},
  doi = {10.1016/j.preghy.2026.101545}
}
Kostenlos starten →